Vaccination for Meningitis

by Sheela Philomena on  May 19, 2011 at 9:42 AM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

A novel vaccine against Meningitis A - a strain which accounts for 80-85 percent of meningitis cases brings hope to Burkina Faso. Bacterial meningitis, which causes deadly epidemics, sparks fear in the 25-country meningitis belt which spreads from Senegal to Ethiopia -- encompassing many of the world's poorest countries.
 Vaccination for Meningitis
Vaccination for Meningitis

Microsoft magnate Bill Gates, rallying world leaders on Tuesday to invest in vaccines, invent new ones and make them cheap enough for poor countries, puts the terror of meningitis succinctly.

"A perfectly healthy child can be playing with friends one minute and be dead in a matter of hours," he told the World Health Assembly in Geneva.

In 1996, when the deadliest epidemic ever tore through this region, infecting more than 250,000 people, the only weapon against it was a short-lasting vaccine used only once epidemics were already in full swing.

In the 2009 epidemic season, 5,342 people died across 14 African countries, according to the World Health Organisation.

In a novel public-private partnership, MenAfriVac was developed specifically for Africa and rapidly brought to market -- manufactured by the Serum Institute of India -- for less than 50 cents per dose.

It usually costs about $500 million to develop and bring a new vaccine to market, something Bill Gates and his foundation are trying to change.

MenAfricVAc was rolled out in Burkina Faso, Mali, and Niger in December 2010.

In Burkina Faso there has been only one case of Meningitis-A in 2011, Gates told the meeting in Geneva.

Doctor Sylvestre Kiendrebeogo at Burkina Faso's health ministry told AFP this was compared to 17 cases in the same period in 2010.

"We have vaccinated 11.5 million people. There are very few cases since the vaccination."

Gates, who wants the same kind of action to see five or six new vaccines introduced in the next decade, said this data makes him hopeful.

"For centuries, meningitis terrorised a region of 400 million people. This vaccine can help end the terror.

"We need to continue creating and delivering more vaccines, but finally, for the first time, we have every reason to expect progress. A bleak picture has turned bright."

For Traore Sekou, 64, a former railway worker in Ouagadougou, who also had his three children vaccinated recently, not having to worry about meningitis is a huge relief.

"I have seen many colleagues lose their children. Now I am reassured because the nurse told us the vaccine immunises for 10 years. Aside from malaria it is the disease which kills the most here so if it is eliminated we can get by because for malaria, we sleep under nets."

If MenAfriVac is introduced throughout southern Africa, the resulting reduction in meningitis cases could free up to $120 million from national budgets by 2010, according to the World Health Organisation.

Source: AFP

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Billionaires like Bill Gates are doing good to improve the lives of people from impoverished people. Hoping that those who have money will follow in his steps. A lot of countries especially in Africa needs help. It's good that there is a cheaper vaccine for meningitis and that almost all children were vaccinated in the country.

More News on:

Meningitis Top 10 Vaccine Myths Debunked 

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive